300347 泰格医药
已收盘 05-11 15:00:00
资讯
新帖
简况
泰格医药（300347）披露将参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会，5月7日股价下跌1.57%
证券之星 · 05-07
泰格医药（300347）披露将参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会，5月7日股价下跌1.57%
高盛：下调泰格医药(03347)目标价至59.4港元 维持“买入”评级
智通财经 · 05-04
高盛：下调泰格医药(03347)目标价至59.4港元 维持“买入”评级
每周股票复盘：泰格医药（300347）Q1营收增15.17%
证券之星 · 05-03
每周股票复盘：泰格医药（300347）Q1营收增15.17%
泰格医药（300347）2026年一季报简析：增收不增利，公司应收账款体量较大
证券之星 · 04-30
泰格医药（300347）2026年一季报简析：增收不增利，公司应收账款体量较大
泰格医药(03347)将于7月31日派发末期股息每10股1.26元
智通财经 · 04-29
泰格医药(03347)将于7月31日派发末期股息每10股1.26元
方达控股季度净利润报290万美元
投资观察 · 04-28
方达控股季度净利润报290万美元
泰格医药(03347)一季度归母净利润4904.3万元，同比下降70.36%
智通财经 · 04-28
泰格医药(03347)一季度归母净利润4904.3万元，同比下降70.36%
泰格医药：截至2025年12月31日，公司股东人数为49,327人
证券之星 · 04-27
泰格医药：截至2025年12月31日，公司股东人数为49,327人
Schroders PLC增持泰格医药(03347)29.98万股 每股作价约43.62港元
智通财经网 · 04-23
Schroders PLC增持泰格医药(03347)29.98万股 每股作价约43.62港元
泰格医药与英硅智能签署战略合作
第一财经 · 04-17
泰格医药与英硅智能签署战略合作
泰雅科技与阿里云达成全面合作 共建临床试验AI新生态
第一财经 · 04-16
泰雅科技与阿里云达成全面合作 共建临床试验AI新生态
泰格医药：公司是一家专注于为新药研发提供临床试验全过程专业服务的合同研究组织（CRO）
证券之星 · 04-15
泰格医药：公司是一家专注于为新药研发提供临床试验全过程专业服务的合同研究组织（CRO）
4月14日泰格医药涨6.05%，中欧医疗健康混合A基金重仓该股
证券之星 · 04-14
4月14日泰格医药涨6.05%，中欧医疗健康混合A基金重仓该股
泰格医药新注册《基于Excel的数据自动提取工具软件V1.0》项目的软件著作权
证券之星 · 04-03
泰格医药新注册《基于Excel的数据自动提取工具软件V1.0》项目的软件著作权
泰格医药新注册《基于Excel的分包合同生成工具软件V1.0》项目的软件著作权
证券之星 · 04-02
泰格医药新注册《基于Excel的分包合同生成工具软件V1.0》项目的软件著作权
泰格医药：与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定
人民财讯 · 04-01
泰格医药：与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定
泰格医药涨5.98%，东吴证券一个月前给出“买入”评级
证券之星 · 04-01
泰格医药涨5.98%，东吴证券一个月前给出“买入”评级
泰格医药2025年归母净利润大增119%，扣非净利润下滑58%
蓝鲸财经 · 03-31
泰格医药2025年归母净利润大增119%，扣非净利润下滑58%
泰格医药：关于董事会换届选举的公告
证券日报 · 03-30
泰格医药：关于董事会换届选举的公告
泰格医药(300347.SZ)发布2025年度业绩，归母净利润8.88亿元，增长119.15%
智通财经 · 03-30
泰格医药(300347.SZ)发布2025年度业绩，归母净利润8.88亿元，增长119.15%
暂无数据
公司概况
公司名称：
杭州泰格医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2012-08-17
主营业务：
杭州泰格医药科技股份有限公司的主营业务是为新药研发提供临床试验全过程专业服务的合同研究组织（CRO），为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。公司的主要产品是临床运营、临床药理、注册与法规事务、科学事务、医学翻译、药物警戒、真实世界研究、第三方稽查、培训等服务、数据管理及统计分析、临床试验现场管理、受试者招募、医学影像、实验室。
发行价格：
37.88
{"stockData":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":52.4,"timestamp":1778483034000,"preClose":51.16,"halted":0,"volume":13335805,"delay":0,"changeRate":0.0242,"floatShares":566000000,"shares":861000000,"eps":0.896,"marketStatus":"已收盘","change":1.24,"latestTime":"05-11 15:00:00","open":51.2,"high":52.67,"low":50.69,"amount":689000000,"amplitude":0.0387,"askPrice":52.41,"askSize":4,"bidPrice":52.4,"bidSize":300,"shortable":0,"etf":0,"ttmEps":0.896,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778549400000},"marketStatusCode":5,"adr":0,"adjPreClose":51.16,"symbolType":"stock","openAndCloseTimeList":[[1778463000000,1778470200000],[1778475600000,1778482800000]],"highLimit":56.28,"lowLimit":46.04,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":861026050,"isCdr":false,"pbRate":2.11,"roa":"--","peRate":58.482143,"roe":"0.23%","epsLYR":1.04,"committee":0.785455,"marketValue":45118000000,"turnoverRate":0.0236,"status":0,"hkstockBrief":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":38.6,"timestamp":1778486883006,"preClose":38.18,"halted":0,"volume":1371400,"delay":0,"premium":"-36.10"},"floatMarketCap":29670000000},"requestUrl":"/m/hq/s/300347/tweets","defaultTab":"tweets","newsList":[{"id":"2633411477","title":"泰格医药（300347）披露将参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会，5月7日股价下跌1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633411477","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633411477?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:47","pubTimestamp":1778147233,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，泰格医药报收于53.13元，较前一交易日下跌1.57%，最新总市值为457.46亿元。该股当日开盘53.65元，最高54.18元，最低52.92元，成交额达6.59亿元，换手率为2.19%。近日，杭州泰格医药科技股份有限公司披露《关于参加浙江辖区上市公司2026年投资者网上集体接待日暨2025年度业绩说明会的公告》。公司高管将就2025年度业绩、公司治理、发展战略、经营状况等问题与投资者交流。公司现面向投资者公开征集问题，截止时间为2026年5月12日15:00。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700029889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK1583","LU1146622755.USD","BK0216","BK1141","03347","BK1576","BK0174","BK0077","300347","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632279933","title":"高盛：下调泰格医药(03347)目标价至59.4港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2632279933","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632279933?lang=zh_cn&edition=full","pubTime":"2026-05-04 14:36","pubTimestamp":1777876599,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，高盛发布研报称，将泰格医药(03347，300347.SZ)2026至2028年盈利预测下调12%、1%及4%，反映AI投资增加。泰格医药H股目标价由61.4港元下调至59.4港元，A股目标价由76.2元人民币下调至75.2元人民币，均维持“买入”评级。报告指，泰格医药首季收入同比增长15.2%至18亿元人民币，高于该行预期，受惠于国内创新药研发活动带动临床试验服务复苏。但期内经调整纯利1.2亿元人民币，低于该行预期的1.4亿元人民币，主因毛利率修复较预期慢，整体毛利率受旧合同执行、汇率因素及部分业务持续价格压力影响，降至26.6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300347","03347","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632671668","title":"每周股票复盘：泰格医药（300347）Q1营收增15.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632671668","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632671668?lang=zh_cn&edition=full","pubTime":"2026-05-03 01:46","pubTimestamp":1777743975,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，泰格医药报收于55.2元，较上周的56.02元下跌1.46%。本周，泰格医药4月28日盘中最高价报59.5元。本周关注点业绩披露要点：泰格医药2026年一季报显示，一季度主营收入18.01亿元，同比上升15.17%。业绩披露要点泰格医药2026年一季报显示，一季度公司主营收入18.01亿元，同比上升15.17%；归母净利润4904.31万元，同比下降70.36%；扣非净利润1.2亿元，同比上升17.65%；负债率14.71%，投资收益3666.04万元，财务费用2215.99万元，毛利率26.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631578878","title":"泰格医药（300347）2026年一季报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2631578878","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631578878?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:41","pubTimestamp":1777502509,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期泰格医药发布2026年一季报。截至本报告期末，公司营业总收入18.01亿元，同比上升15.17%，归母净利润4904.31万元，同比下降70.36%。本报告期泰格医药公司应收账款体量较大，当期应收账款占最新年报归母净利润比达153.2%。本次财报公布的各项数据指标表现一般。去年的净利率为11.78%，算上全部成本后，公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000022594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0028","03347","BK0216","BK1576","BK0174","BK1583","LU1146622755.USD","300347","BK0077","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631595451","title":"泰格医药(03347)将于7月31日派发末期股息每10股1.26元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631595451","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631595451?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:38","pubTimestamp":1777455527,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，该公司将于2026年7月31日派发截至2025年12月31日止年度的末期股息每10股1.26元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK4585","BK4588","BK1576","BK0077","300347","03347","BK0216","LU1820825898.SGD","VIG","BK0174","LU1146622755.USD","BK1583","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191478174","title":"方达控股季度净利润报290万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191478174","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191478174?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:47","pubTimestamp":1777376862,"startTime":"0","endTime":"0","summary":"方达控股公司最新财报显示，本季度实现净利润290万美元。这一业绩数据反映了公司在当前财季的盈利表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK1576","BK1583","BK0174","LU1820825898.SGD","BK0077","LU1146622755.USD","01521","300347","BK1141","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630376299","title":"泰格医药(03347)一季度归母净利润4904.3万元，同比下降70.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630376299","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630376299?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:42","pubTimestamp":1777365747,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，2026年第一季度，营业收入18.01亿元，同比增长15.17%;归属于上市公司股东的净利润4904.3万元，同比下降70.36%;基本每股收益0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630382394","title":"泰格医药：截至2025年12月31日，公司股东人数为49,327人","url":"https://stock-news.laohu8.com/highlight/detail?id=2630382394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630382394?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:51","pubTimestamp":1777294281,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药(300347)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：请问目前股东人数是多少？近期大股东或者公司是否有回购计划？泰格医药回复：投资者您好，根据公司2025年度报告中股东相关章节披露：截至2025年12月31日，公司股东人数为49,327人。公司后续如有回购计划会及时于巨潮资讯网披露公告，请您关注公司公告。谢谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700042924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0216","BK1576","300347","BK0028","BK1141","BK1583","BK0174","LU1146622755.USD","03347","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629076839","title":"Schroders PLC增持泰格医药(03347)29.98万股 每股作价约43.62港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076839","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629076839?lang=zh_cn&edition=full","pubTime":"2026-04-23 19:46","pubTimestamp":1776944807,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，4月20日，Schroders PLC增持泰格医药(03347)29.98万股，每股作价43.6247港元，总金额约为1307.87万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260423/20260423194716_95321.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260423/20260423194716_95321.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1820825898.SGD","BK1576","BK0028","BK1141","BK1583","BK0077","BK0174","300347","EWH","03347","LU1146622755.USD","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628129223","title":"泰格医药与英硅智能签署战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2628129223","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628129223?lang=zh_cn&edition=full","pubTime":"2026-04-17 09:06","pubTimestamp":1776387982,"startTime":"0","endTime":"0","summary":"2026年4月16日，杭州泰格医药科技股份有限公司与生成式人工智能驱动的临床阶段生物医药科技公司英硅智能签署战略合作协议。双方将围绕创新药产品的临床研究开展长期战略合作，通过AI来驱动药物研发提速增效，助力创新药更快落地、惠及全球患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604173708366528.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604173708366528.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0077","LU1820825898.SGD","BK0174","BK1576","LU1146622755.USD","BK0216","BK1583","03347","BK0028","BK1141","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627229209","title":"泰雅科技与阿里云达成全面合作 共建临床试验AI新生态","url":"https://stock-news.laohu8.com/highlight/detail?id=2627229209","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627229209?lang=zh_cn&edition=full","pubTime":"2026-04-16 19:17","pubTimestamp":1776338245,"startTime":"0","endTime":"0","summary":"据泰格医药消息，2026年4月16日，泰格医药及子公司杭州泰雅语言科技有限责任公司（简称“泰雅科技”）高层代表团赴阿里云云谷园区参观交流。此次访问旨在进一步加强双方在前沿技术领域的互动，双方就临床试验人工智能（AI）技术的应用前景进行了深入探讨，并宣布将在该领域展开全面合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604163707617473.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604163707617473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1688375341.USD","IE00BMPRXR70.SGD","LU1642822792.SGD","LU0417516902.SGD","LU0737861772.HKD","LU0577902371.SGD","09988","LU0106259558.USD","LU0455707207.USD","SG9999006597.SGD","LU0651946864.USD","LU1051768304.USD","LU2476274308.USD","LU0181495838.USD","LU1188198961.HKD","LU0819123356.HKD","LU0708995153.HKD","LU0762541174.USD","LU0865486749.SGD","LU0463099449.HKD","LU0762540952.USD","89988","LU0029875118.USD","IE0034224299.USD","LU0029874905.USD","LU0456846285.SGD","LU0488056044.USD","LU0315179316.USD","HK0000320223.HKD","HK0000306701.USD","BK1588","LU0130518102.USD","LU0531971595.HKD","LU0348783233.USD","SG9999006514.SGD","LU0441854154.USD","LU0572944931.SGD","LU0345776255.USD","LU0823426480.USD","LU0307460666.USD","LU0541502299.USD","LU0886674414.USD","LU0605514214.HKD","LU1115378108.SGD","LU0543330566.HKD","LU1868838027.USD","LU0831103253.SGD","LU0039217434.USD","LU2097828805.USD","BK1586","LU1880398471.USD","ALBmain","LU1515016050.SGD","LU0173614495.USD","LU0823039010.USD","LU0700851271.USD","LU0862451753.SGD","LU1251922891.USD","LU0823413660.USD","LU0228659784.USD","LU1044875133.USD","LU1323998911.USD","LU2125910500.SGD","LU1981816686.USD","LU1720051017.SGD","LU2097828474.EUR","SG9999002562.SGD","LU0634319403.HKD","LU1201861165.SGD","LU0132412106.USD","LU0828237510.HKD","LU0048388663.USD","LU0072462343.USD","LU1211504680.USD","LU0143863784.USD","LU0449509016.USD","LU0130103400.USD","LU1880383366.USD","LU1568876335.HKD","BK1575","LU0370786039.SGD","LU0642271901.SGD","BK1517","HK0000286598.CNH","LU2097828631.EUR","LU0149721374.USD","LU1242518857.USD","LU0516422366.SGD","LU0640798160.USD","LU0254981946.USD","LU1831875114.USD","LU3063872942.SGD","LU0348805143.USD","LU1282649810.SGD","LU0011963245.USD","SG9999001903.USD","LU0890818403.SGD","LU0417516571.SGD","SG9999014674.SGD","LU0607220059.USD","IE00B0JY6N72.USD","LU0051755006.USD","HK0000151867.HKD","LU0540923850.HKD","LU0384037296.USD","LU0143863198.USD","BK1584","LU0577902611.USD","LU0211977185.USD","LU0345775950.USD","LU1328277881.USD","LU1303224171.USD","LU1316542783.SGD","LU1439103000.SGD","LU0084288322.USD","LU0708995583.HKD","LU0047713382.USD","LU1794554557.SGD","LU0049853897.USD","LU1242518931.SGD","LU2476274720.SGD","SG9999001226.SGD","LU0117844026.USD","LU0251144936.SGD","LU0675040207.SGD","BK1608","LU1048596156.SGD","LU0791591158.USD","LU1328615791.USD","BK1502","LU0315178854.USD","LU1048484197.HKD","LU0762542818.HKD","LU0823041008.USD","LU0320764599.SGD","LU0502904849.HKD","LU0577902298.EUR","LU0228367735.SGD","LU1810669033.SGD","LU1044874839.SGD","IE00BPRC5H50.USD","LU0589944569.HKD","HK0000107257.USD","LU1282649141.HKD","LU2488822045.USD","LU0588545490.SGD","LU1282649067.USD","LU1366334578.USD","LU0611395673.USD","LU2097828714.EUR","LU0293314216.USD","SGXZ90724238.SGD","LU1769817096.USD","LU0054237671.USD","SG9999004220.SGD","LU0264606111.USD","BABA","LU2045819591.USD","LU1961090484.USD","LU0348788117.USD","IE0003895053.USD","LU0499858438.USD","LU0052750758.USD","LU0871576103.HKD","LU0214875030.USD","LU2125910849.SGD","LU0261947096.USD","LU0862451837.USD","IE00BMPRXN33.USD","LU0235996351.USD","LU0630378429.USD","LU0831093199.SGD","LU0320764243.SGD","LU0499858602.USD","LU1504937902.USD","LU0650527681.SGD","LU0823040885.USD","LU1568876251.USD","LU0326950275.SGD","SG9999001093.SGD","300347","IE00B0169N27.USD","LU0149534421.HKD","IE0008368304.USD","LU1956131251.USD","LU0128522744.USD","LU0577902538.SGD","LU1770036033.HKD","LU0648000940.SGD","LU0320764755.SGD","LU1808992512.USD","LU1770034418.SGD","LU0449515922.USD","LU0127658192.USD","LU2357305700.SGD","LU0163747925.USD","LU1868837565.USD","LU0594300179.USD","LU1224444064.USD","LU0572939691.SGD","LU0823413587.USD","HK0000306685.HKD","LU0588546209.SGD","LU0608807946.USD","IE0032431581.USD","LU0106252389.USD","LU0043850808.USD","LU0828237940.HKD","LU0588545904.SGD","LU1196710864.SGD","LU0061477393.USD","LU0543330483.HKD","LU0979878070.USD","LU0791590937.USD","LU0431992006.USD","LU0593848301.USD","SG9999002463.SGD","LU0128522157.USD","LU2449936058.SGD","LU0873338254.USD","IE00BZ08YT58.USD","SG9999000459.SGD","LU0348784397.USD","LU0856984785.SGD","LU0516423174.USD","LU1023057109.AUD","LU0197773673.USD","LU0117841782.USD","LU1655091459.SGD","LU0823038988.USD","LU0868486357.SGD","LU0823397103.USD","LU1224709979.USD","SGXZ62798434.SGD","LU1282651121.HKD","LU0164880469.USD","LU0196878994.USD","LU1719994722.HKD","LU0821914370.USD","LU0359202008.SGD","LU1720051108.HKD","LU1880383440.USD","LU0327786744.USD","LU0417516738.SGD","LU0456827905.SGD","LU2039709279.SGD","LU0314109678.HKD","LU0651947912.USD","LU0588545730.USD","HK0000320264.USD","LU0244354667.USD","LU0210526637.USD","LU0348735423.USD","LU2778985437.USD","LU1880398554.USD","LU1720050803.USD","LU2152927971.USD","IE00B3M56506.USD","LU0164872284.USD","SG9999001689.USD","LU1051769294.HKD","IE00BZ08YS42.EUR","LU0197773160.USD","LU0348827113.USD","LU0516422440.USD","LU1807302812.USD","BK1610","BK1618","LU0477156797.USD","LU0329678337.USD","LU0737861699.HKD","LU0819121731.USD","LU0048597586.USD","03347","LU0608807433.USD","LU0287142896.SGD","IE00BZ08YR35.GBP","LU0096374516.USD","LU2294711473.HKD","LU0229945570.USD","LU0165289439.USD","LU0348825331.USD","LU0823426308.USD","LU0231483743.USD","LU0516422952.EUR","LU0630378692.HKD","SG9999001051.SGD","BK1142","IE00B5MMRT66.SGD","SG9999002828.SGD","LU1813983027.USD","LU1481107354.HKD","LU0672654166.SGD","LU0396098781.USD","LU0516423091.SGD","LU1366334651.USD","LU1044876610.USD","LU0469268626.HKD","SGXZ86797644.SGD","LU0048580855.USD","LU0561508036.HKD","LU0106959298.USD","BK1615","LU2097828557.USD","LU0210527791.USD","LU0259732245.USD","LU0648948544.HKD","LU2257852520.SGD","LU0359201885.HKD","HBBD.SI","LU0823397285.USD","LU1769817179.HKD","BK1501","LU0140636845.USD","LU0164865239.USD","LU0328353924.USD","SG9999000327.SGD","LU0348783662.USD","LU0541501648.USD","LU0577902454.USD","LU0359201612.USD","LU2087589342.USD","LU0169518387.USD","LU0054450605.USD","LU0531970944.HKD","LU2293587155.HKD","IE00B543WZ88.USD","LU1282651048.USD","LU0261950983.USD","LU1048588211.SGD","BK1249","BK1521","LU2399975544.HKD","LU1960683339.HKD","LU2097829019.USD","LU0594300419.USD","LU2242644610.SGD","LU0784639295.USD","LU1993786604.SGD","LU1548497426.USD","LU0572940350.SGD","LU0898667661.SGD","LU0329678170.USD","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472985","title":"泰格医药：公司是一家专注于为新药研发提供临床试验全过程专业服务的合同研究组织（CRO）","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472985","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472985?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:34","pubTimestamp":1776224075,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药04月15日在投资者关系平台上答复投资者关心的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0028","03347","BK0216","BK1576","BK0174","BK1583","LU1146622755.USD","300347","BK0077","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627416379","title":"4月14日泰格医药涨6.05%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627416379","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627416379?lang=zh_cn&edition=full","pubTime":"2026-04-14 16:16","pubTimestamp":1776154570,"startTime":"0","endTime":"0","summary":"证券之星消息，4月14日泰格医药涨6.05%，收盘报59.45元，换手率2.52%，成交量14.28万手，成交额8.22亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共97家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为138.43亿元，最新净值1.8526，较上一交易日下跌0.33%，近一年上涨20.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400025383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","03347","300347","BK0077","BK1576","BK0216","BK1583","BK1141","LU1820825898.SGD","BK0028","159760","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568929","title":"泰格医药新注册《基于Excel的数据自动提取工具软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624568929?lang=zh_cn&edition=full","pubTime":"2026-04-03 02:17","pubTimestamp":1775153832,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰格医药新注册了《基于Excel的数据自动提取工具软件V1.0》项目的软件著作权。今年以来泰格医药新注册软件著作权6个，较去年同期增加了50%。结合公司2025年年报财务数据，2025年公司在研发方面投入了2.58亿元，同比增8.08%。通过天眼查大数据分析，杭州泰格医药科技股份有限公司共对外投资了60家企业，参与招投标项目51次；财产线索方面有商标信息79条，专利信息18条，著作权信息179条；此外企业还拥有行政许可45个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300001860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","LU1146622755.USD","BK1141","03347","BK1576","LU1820825898.SGD","BK0174","BK0216","BK1583","300347","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624545579","title":"泰格医药新注册《基于Excel的分包合同生成工具软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624545579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624545579?lang=zh_cn&edition=full","pubTime":"2026-04-02 02:04","pubTimestamp":1775066656,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰格医药新注册了《基于Excel的分包合同生成工具软件V1.0》项目的软件著作权。今年以来泰格医药新注册软件著作权5个，较去年同期增加了25%。结合公司2025年年报财务数据，2025年公司在研发方面投入了2.58亿元，同比增8.08%。通过天眼查大数据分析，杭州泰格医药科技股份有限公司共对外投资了60家企业，参与招投标项目51次；财产线索方面有商标信息79条，专利信息18条，著作权信息179条；此外企业还拥有行政许可45个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200000796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0077","03347","BK1141","LU1146622755.USD","300347","BK1583","BK0216","BK0028","LU1820825898.SGD","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595533","title":"泰格医药：与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595533","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595533?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:19","pubTimestamp":1775031540,"startTime":"0","endTime":"0","summary":"【泰格医药：与某全球龙头MNC签署战略合作协议 参与其全球早期临床研究策略制定】泰格医药3月30日在业绩说明会上表示，开年业务亮点：与某全球龙头MNC签署战略合作协议，参与其全球早期临床研究策略制定，提供全方位支持。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604013691912750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK0174","BK0077","03347","BK1576","BK0028","300347","BK1583","LU1146622755.USD","BK0216","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595849","title":"泰格医药涨5.98%，东吴证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595849?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:16","pubTimestamp":1775031411,"startTime":"0","endTime":"0","summary":"今日泰格医药涨5.98%，收盘报57.05元。2026年2月15日，东吴证券研究员朱国广发布了对泰格医药的研报《泰格医药：临床CRO龙头，扬帆启航新征程》，该研报对泰格医药给出“买入”评级。研报中预计2025-2027年营收71.29/80.19/93.27亿元，同比+7.97%/12.48%/16.31%；归母净利润约11.14/13.57/18.17亿元，同比+175%/22%/34%，对应PE为47/39/29X，首次覆盖，给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为光大证券的宋硕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623589907","title":"泰格医药2025年归母净利润大增119%，扣非净利润下滑58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623589907","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623589907?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:17","pubTimestamp":1774959423,"startTime":"0","endTime":"0","summary":"公司2025年归母净利润达8.88亿元，同比增长119.15%，但扣除非经常性损益后的净利润为3.55亿元，同比下降58.47%。非经常性损益总额为5.33亿元，占归母净利润比重达59.99%，接近六成。该板块毛利率由29.56%下滑至20.09%，降幅达9.47个百分点，直接导致公司整体毛利率由33.27%下降至26.53%，降幅6.74个百分点。该板块虽仍为第二大业务板块，但其收入占比已退居次席，且盈利能力弱化对扣非净利润产生实质性冲击。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774954342729329489","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["03347","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623346850","title":"泰格医药：关于董事会换届选举的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2623346850","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623346850?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:31","pubTimestamp":1774877460,"startTime":"0","endTime":"0","summary":"证券日报网讯3月30日，泰格医药发布公告称，2026年3月30日，公司召开第五届董事会第二十三次会议，审议通过《关于公司董事会换届选举暨第六届董事会董事候选人提名的议案》，提名叶小平先生、曹晓春女士、吴灏先生、闻增玉先生为公司第六届董事会执行董事候选人；提名袁华刚先生、刘毓文女士、萧耀熙先生为公司第六届董事会独立非执行董事候选人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603303689149064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1820825898.SGD","BK0216","BK1576","300347","BK0028","BK1141","BK1583","BK0174","LU1146622755.USD","03347","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311294","title":"泰格医药(300347.SZ)发布2025年度业绩，归母净利润8.88亿元，增长119.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311294","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623311294?lang=zh_cn&edition=full","pubTime":"2026-03-30 19:06","pubTimestamp":1774868809,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(300347.SZ)发布2025年年度报告，该公司营业收入为68.33亿元，同比增长3.48%。归属于上市公司股东的净利润为8.88亿元，同比增长119.15%。归属于上市公司股东的扣除非经常性损益的净利润为3.55亿元，同比减少58.47%。基本每股收益为1.04元。此外，拟向全体股东每10股派发现金红利1.26元(含税)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","300347"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778512514829,"stockEarnings":[{"period":"1week","weight":-0.0732},{"period":"1month","weight":-0.0871},{"period":"3month","weight":-0.2207},{"period":"6month","weight":-0.1228},{"period":"1year","weight":0.1194},{"period":"ytd","weight":-0.0977}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州泰格医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2012-08-17","address":"浙江省杭州市滨江区浦沿街道陆家潭街508号6层601-610室","registeredCapital":"86102万元","survey":" 杭州泰格医药科技股份有限公司的主营业务是为新药研发提供临床试验全过程专业服务的合同研究组织（CRO），为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。公司的主要产品是临床运营、临床药理、注册与法规事务、科学事务、医学翻译、药物警戒、真实世界研究、第三方稽查、培训等服务、数据管理及统计分析、临床试验现场管理、受试者招募、医学影像、实验室。","listedPrice":37.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,300347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}